What is Rossari Biotech Ltd. Quarterly Revenue?

Rossari Biotech Ltd. Quarterly Revenue Rossari Biotech Sep-2026 Quarterly Revenue is Rs 497 Cr which is growth of 18.1% YoY.

What is Rossari Biotech Ltd. Quarterly Net Profit?

Rossari Biotech Ltd. Quarterly Net Profit Rossari Biotech Sep-2026 Quarterly Net Profit is Rs 34 Cr which is growth of 9.5% YoY.

What is Rossari Biotech Ltd. Annual Revenue?

Rossari Biotech Ltd. Annual Revenue Rossari Biotech Mar-2026 Annual Revenue is Rs 1,779 Cr which is growth of 23.8% YoY.

What is Rossari Biotech Ltd. Annual Net Profit?

Rossari Biotech Ltd. Annual Net Profit Rossari Biotech Mar-2026 Annual Net Profit is Rs 143 Cr which is growth of 24.5% YoY.

What is Rossari Biotech Ltd. Total Shareholders Fund?

Rossari Biotech Ltd. Total Shareholders Fund Rossari Biotech Mar-2026 Total Shareholders Fund is Rs 1,218 Cr which is growth of 13.1% YoY.

What is Rossari Biotech Ltd. Total Assets?

Rossari Biotech Ltd. Total Assets Rossari Biotech Mar-2026 Total Assets is Rs 1,764 Cr which is growth of 21.6% YoY.

What is Rossari Biotech Ltd. Book Value Per Share?

Rossari Biotech Ltd. Book Value Per Share Rossari Biotech Mar-2026 Book Value Per Share is 220 Rs which is growth of 13.1% YoY.

What is Rossari Biotech Ltd. ROE?

Rossari Biotech Ltd. ROE Rossari Biotech Mar-2026 ROE is 12% which is growth of 1.1% YoY.

What is Rossari Biotech Ltd. Cash From Operating Activity?

Rossari Biotech Ltd. Cash From Operating Activity Rossari Biotech Mar-2026 Cash From Operating Activity is Rs 59 Cr which is growth of -36.3% YoY.

What is Rossari Biotech Ltd. Net Cash Flow?

Rossari Biotech Ltd. Net Cash Flow Rossari Biotech Mar-2026 Net Cash Flow is Rs 36 Cr which is growth of 464.8% YoY.

Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213

Mid-range Performer

Download real time

Export Demand EBITDA per Kg

0.40(0.09%)

34.85% Fall from 52W High

97,973

NSE+BSE Volume

NSE 09 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Rossari Biotech quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Rossari Biotech share price target, revenues, EPS, net income and more

Rossari Biotech quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Rossari Biotech Sep-2026 Quarterly Revenue is Rs 497 Cr which is growth of 18.1% YoY.
POSITIVE
Quarterly Net Profit Rossari Biotech Sep-2026 Quarterly Net Profit is Rs 34 Cr which is growth of 9.5% YoY.

Rossari Biotech Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Sep '26	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23
TOTAL_SR_Q Total Rev. ⌄	497	484.5	538.9	451.8	420.9	367.5	429.1	369.3	337.1	302	315.2	300.9	334
SR_Q Operating Rev.	495.3	482.3	516.1	450.7	419.5	365.8	426.7	368.3	336	300.7	313.8	298.8	332
OI_Q Other Income	1.7	2.2	22.7	1.1	1.4	1.7	2.4	1	1.1	1.3	1.3	2.1	2
OEXPNS_Q Operating Exp.	438	425.9	452.5	400.3	369.1	321.8	374.5	318.3	291.7	260.9	272.1	257.6	289.7
OEXPNS_Q Operating Exp.	438	425.9	452.5	400.3	369.1	321.8	374.5	318.3	291.7	260.9	272.1	257.6	289.7
OP_Q Operating Profit	57.3	56.4	63.6	50.4	50.4	43.9	52.2	50	44.3	39.8	41.7	41.1	42.3
OPMPCT_Q Operating Profit Margin %	11.56%	11.70%	12.32%	11.18%	12.02%	12.01%	12.23%	13.57%	13.18%	13.24%	13.30%	13.77%	12.75%
DEP_Q Depr.	10.7	8.3	9	7.5	7.3	7.2	7.7	7.4	6.5	6.1	6.6	5.8	6.3
INT_Q Interest	2.1	3.8	3.8	4	2.5	3.1	3.1	2.3	1.9	2.3	1.7	2.6	2.5
PBT_Q Profit Before Tax	46.2	46.4	73.6	40.1	42	35.4	43.9	41.3	36.9	32.7	34.7	34.8	35.5
TAX_Q Tax	11.9	12.2	18.8	9.5	10.7	9.2	11.5	10.6	9.5	8.3	8.6	9.3	9.1
NP_Q Net Profit	34.2	34.3	54.7	30.6	31.3	26.2	32.4	30.6	27.4	24.3	26.2	25.5	26.4
EPS_adj_Q EPS Adj. latest	6.2	6.2	9.9	5.5	5.6	4.7	5.8	5.5	5	4.4	4.7	4.6	4.8
NP_TTM Net profit TTM	153.9	150.9	142.8	120.5	120.5	116.7	114.7	108.6	103.5	102.4	99.6	96.6	88.5
EPS_TTM Basic EPS TTM	27.8	27.2	25.8	21.8	21.8	21.1	20.7	19.6	18.7	18.5	18	17.5	16
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Rossari Biotech competitor comparison and performance snapshot within industry

Rossari Biotech annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Rossari Biotech Mar-2026 Annual Revenue is Rs 1,779 Cr which is growth of 23.8% YoY.
POSITIVE
Annual Net Profit Rossari Biotech Mar-2026 Annual Net Profit is Rs 143 Cr which is growth of 24.5% YoY.

Rossari Biotech Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	22%	20.5%	1,972.1	1,779.1	1,437.4	1,209.7	978.8	1,085.5	700.6	603.7	517.2	299.6	234.4	178.5
TotalOperatingRevenues_A Operating Rev. Ann.	21.6%	20.5%	1,944.3	1,752.1	1,431.6	1,202.9	975.2	1,072.8	690.4	600.1	515.9	298.5	233.5	178.1
OI_A Other Income Ann.	95.7%	21.5%	27.7	27	5.7	6.8	3.6	12.7	10.2	3.6	1.2	1.1	0.9	0.4
OEXPNS_A Operating Exp. Ann.	21.9%	22.1%	1,716.7	1,543.7	1,245.4	1,041.7	852.5	950.1	569.6	495.1	437.3	253.7	209.2	165.8
OEXPNS_A Operating Exp. Ann.	21.9%	22.1%	1,716.7	1,543.7	1,245.4	1,041.7	852.5	950.1	569.6	495.1	437.3	253.7	209.2	165.8
OP_A Operating Profit Ann.	19.3%	11.5%	227.7	208.3	186.2	161.3	122.7	122.8	120.9	105	78.7	44.8	24.3	12.3
OPMPCT_A OPM Ann. %	-2.2%	-7.5%		11.71%	12.96%	13.33%	12.53%	11.31%	17.25%	17.39%	15.21%	14.94%	10.37%	6.89%
TotalExpenses_A Total Exp. Ann. ⌄	21.6%	21.7%		1,588	1,282.7	1,075.6	883.1	978.9	594.6	515.6	452.7	260.2	215.6	173.7
OtherExpenses_A Other Exp. Ann.	22.6%	15.6%	183.9	167.5	138.3	93.1	90.9	86.6	81.3	86.3	72.5	30.4	24.2	23.9
EmployeeBenefitExpenses_A Employee Exp. Ann.	6.6%	13.6%	77.8	69.5	60	51.5	57.4	43.5	36.7	37.1	26.5	17.9	14.1	11.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	23%	12.4%		235.3	192	168	126.3	135.5	131.1	108.6	79.9	45.9	25.2	12.7
EBIDTPCT_A EBITDA Ann. margin %	0.8%	-6.7%		13.23%	13.36%	13.89%	12.90%	12.48%	18.71%	17.99%	15.45%	15.31%	10.77%	7.13%
INT_A Interest Ann.	42.8%	34.9%	13.7	13.4	9.6	9.7	4.6	2.5	3	3.7	3.3	1.4	2.1	3.4
DEP_A Depr.	5.9%	6.9%	35.5	30.9	27.7	24.2	26	26.3	22.1	16.9	12.2	5.1	4.3	4.5
PBT_A PBT Ann.	26%	12.5%	206.2	191.1	154.7	134.1	95.6	106.7	106	88.1	64.5	39.4	18.9	4.8
TAX_A Tax Ann.	25.6%	12.4%	52.4	48.2	40	34.5	24.3	27.2	26.9	22.6	16.7	10.5	3.1	1.4
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	26%	12.5%		142.8	114.7	99.6	71.4	79.5	79.1	65.5	47.7	28.9	15.7	3.4
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	26%	12.5%	153.9	142.8	114.7	99.6	71.4	79.5	79.1	65.5	45.5	28.9	15.7	3.4
NETPCT_A NPM Ann. %	3.6%	-6.6%		8.15%	8.01%	8.28%	7.32%	7.40%	11.45%	10.91%	8.81%	9.68%	6.73%	1.91%
EPS_adj_A EPS Adj. latest Ann.	26%	12.5%		25.8	20.7	18	12.9	14.4	14.3	11.8	8.2	5.2	2.8	0.6
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

23.8%

2Y CAGR

21.3%

3Y CAGR

22%

5Y CAGR

20.5%

7Y CAGR

19.3%

10Y CAGR

25.9%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

24.5%

2Y CAGR

19.7%

3Y CAGR

26%

5Y CAGR

12.5%

7Y CAGR

17.7%

10Y CAGR

45.3%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

24%

2Y CAGR

21.7%

3Y CAGR

21.9%

5Y CAGR

22.1%

7Y CAGR

19.7%

10Y CAGR

25%

Operating Expenses Annual Cr growth is higher than historical averages.

Rossari Biotech balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Rossari Biotech Mar-2026 Total Shareholders Fund is Rs 1,218 Cr which is growth of 13.1% YoY.
POSITIVE
Total Assets Rossari Biotech Mar-2026 Total Assets is Rs 1,764 Cr which is growth of 21.6% YoY.

Rossari Biotech Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	12.4%	24.7%	1,218.5	1,077.2	960.3	858.7	784.5	404.4	283.5	124.5	89.5	60.6	45.3
EQCAP_A Equity Share Capital Ann.	0.3%	1.3%	11.1	11.1	11.1	11	11	10.4	10.2	4.4	4.4	4.4	4.4
TotalShareCapital_A Total Share Capital Ann.	0.3%	1.3%	11.1	11.1	11.1	11	11	10.4	10.2	4.4	4.4	4.4	4.4
ReservesAndSurplus_A Reserves Plus Surplus Ann.	12.5%	25.1%	1,207.4	1,066.1	945.6	847.7	770.2	394.1	273.3	120.1	85.1	56.2	40.9
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	12.5%	25.1%	1,207.4	1,066.1	945.6	847.7	770.2	394.1	273.3	120.1	85.1	56.2	40.9
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-13.5%	88.8%	24	19.4	37.7	37.1	1.2	1	36.1	5	4.3	2.4	6.5
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-							0.5
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-	13.6	16.4	10.9					3	3
CL_A Total Current Liabilities Ann. ⌄	31.4%	30.3%	521.2	354.3	283.1	229.9	140.2	138.9	148.7	120.9	61.9	58.8	52
TradePayables_A Trade Payables Ann.	27%	24.3%	366.8	285.9	225.9	178.9	115.8	123.6	97	104.9	41.6	33.6	28.4
OtherCurrentLiabilities_A Other Current Liabilities Ann.	13.3%	14.8%	29.1	34.9	24.6	20	23.5	14.6	24	8.4	1.4	4.5	6.7
ShortTermProvisions_A ST Provisions Ann.	57.4%	41%	3.9	3.4	2.6	1	0.9	0.7	0.7	2.5	1.4	1.1	1.6
TL_A Total Capital Plus Liabilities Ann.	16.1%	26.5%	1,763.6	1,450.9	1,281.2	1,125.7	925.9	544.4	468.3	250.4	155.7	121.8	103.8
FixedAssets_A Fixed Assets Ann. ⌄	24%	13.5%	322.6	213.3	191.9	169.1	178.2	171.1	115.3	84.4	53.7	44.8	43.5
TangibleAssets_A Tangible Assets Ann.	11.7%	4.8%	211.2	171	160.2	151.6	172	167	88.8	75.6	43.7	36.8	35.9
IntangibleAssets_A Intangible Assets Ann.	19.6%	11.9%	6.5	8.2	7.1	3.8	5.4	3.7	4.8	6	0	0.1	0.1
CapitalWorkInProgress_A Capital Work In Progress Ann.	114.1%	222.7%	105	34.1	24.6	10.7	0.8	0.3	21.8	2.8	10	7.9	7.6
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	9.5%	33.3%	860.6	752.8	713.2	655	557.9	204.8	145.6	90.2	59.2	46.2	44.6
NonCurrentInvestments_A Non Current Investments Ann.	2.7%	123%	512.5	493.1	490.6	472.8	371.9	9.3	4.7	0.2	3.2	0.2	0.2
DeferredTaxAssets_A Deferred Tax Assets Ann.	8.3%	101.2%	3.3	6.6	4.3	2.6	1	0.1		1.9	0.8	0.5	0.3
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-								3.7	1.4	0.8	0.6
OtherNonCurrentAssets_A Other Non Current Assets Ann.	28.3%	-2%	22.2	39.7	26.4	10.5	6.8	24.5	25.7
CA_A Total Current Assets Ann. ⌄	24.3%	21.6%	903	698.2	568	470.7	368.1	339.5	322.7	160.1	96.6	75.6	59.2
CurrentInvestments_A Current Investments Ann.	20%	-	35.1	45.3	37.6	20.3	9		10.6
TradeReceivables_A Trade Receivables Ann.	28.6%	30.4%	518.4	374.6	301.9	243.9	181	137.3	93.8	86	59.4	47.3	29
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-13.7%	-9.6%	51.9	16	25.7	80.8	34.8	86	127.2	5.7	0.7	2.1	2
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	639.3%	70.5%	40.4	35.6	24.6	0.1	2.7	2.8	1.2	13.6	1.4	2.7	3.2
OtherCurrentAssets_A Other Current Assets Ann.	82.3%	25.5%	77.5	47.8	27.2	12.8	33.2	24.9	31.8
TA_A Total Assets Ann.	16.1%	26.5%	1,763.6	1,450.9	1,281.2	1,125.7	925.9	544.4	468.3	250.4	155.7	121.8	103.8
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	26.4%	118.4%	253.7	236.5	94.1	125.6	178.3	5.1	21.2		0.1	0.9
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	5.3	5.3	5.3	5.3	5.3	5.3	5.3
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	2.7%	123%	512.5	493.1	490.6	472.8	371.9	9.3	4.7	0.2	3.2	0.2	0.2
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-					9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

21.6%

2Y CAGR

17.3%

3Y CAGR

16.1%

5Y CAGR

26.5%

7Y CAGR

32.2%

10Y CAGR

32.7%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

47.1%

2Y CAGR

35.7%

3Y CAGR

31.4%

5Y CAGR

30.3%

7Y CAGR

23.2%

10Y CAGR

25.9%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

13.1%

2Y CAGR

12.6%

3Y CAGR

12.4%

5Y CAGR

24.7%

7Y CAGR

38.5%

10Y CAGR

39%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Rossari Biotech ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Rossari Biotech Mar-2026 Book Value Per Share is 220 Rs which is growth of 13.1% YoY.
POSITIVE
ROE Rossari Biotech Mar-2026 ROE is 12% which is growth of 1.1% YoY.

Rossari Biotech Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	12.2%	23.1%	220	194.6	173.8	155.7	142.5	77.9	55.9	282.9	203.4	137.7	102.9
ROA_A RoA Ann. %	8.5%	-11.1%	8.09%	7.90%	7.77%	6.34%	8.58%	14.53%	13.99%	18.15%	18.57%	12.90%	3.29%
ROE_A ROE Ann. %	12.1%	-9.7%	11.72%	10.65%	10.37%	8.31%	10.13%	19.55%	23.11%	36.52%	32.31%	25.94%	7.55%
ROCE_A ROCE Ann. %	13.7%	-9.4%	16.45%	14.98%	14.41%	11.19%	13.90%	26.88%	28.71%	52.31%	43.47%	33.28%	15.89%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	1.2%	-6.7%	13.43%	13.40%	13.96%	12.94%	12.62%	18.98%	18.10%	15.48%	15.37%	10.81%	7.15%
PBITMargin_A EBIT Ann. Margin %	4.3%	-5.9%	11.66%	11.47%	11.95%	10.28%	10.18%	15.78%	15.29%	13.12%	13.66%	8.98%	4.62%
PBTMargin_A PBT Ann. Margin %	3.6%	-6.6%	10.90%	10.80%	11.15%	9.80%	9.94%	15.35%	14.68%	12.49%	13.21%	8.07%	2.69%
NETPCT_A NPM Ann. %	3.6%	-6.6%	8.15%	8.01%	8.28%	7.32%	7.40%	11.45%	10.91%	8.81%	9.68%	6.73%	1.91%
ASETTO_A Asset Turnover Ann. %	3.2%	-4.7%	1.1	1.1	1	1	1.5	1.4	1.7	2.5	2.2	2.1	1.7
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-6.8%	-6.7%	1.7	2	2	2.1	2.6	2.4	2.2	1.3	1.6	1.3	1.1
QuickRatio_A Quick Ratio Ann.	-4.4%	-4.9%	1.4	1.5	1.5	1.6	1.9	1.8	1.8	0.9	1	0.9	0.7
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	0	0	0	0	0			-	-	-	-
EarningRetention_A Earning Retention Ann. %	0.7%	0.3%	98.07%	97.60%	97.24%	96.15%	96.54%	96.80%	95.96%	80.65%			93.57%
CashEarningRetention_A Cash Earning Retention Ann. %	0.4%	0.2%	98.41%	98.06%	97.78%	97.18%	97.40%	97.50%	96.79%	84.74%			97.23%
CashEarningRetention_A Cash Earning Retention Ann. %	0.4%	0.2%	98.41%	98.06%	97.78%	97.18%	97.40%	97.50%	96.79%	84.74%			97.23%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-12.8%	-16.4%	2,169.9	3,358.5	3,755.1	3,267.8	4,994.7	5,302.3
EVPerNetSales_A EV Per Net Sales Ann.	-29.3%	-31%	1.2	2.4	3.1	3.4	4.7	7.7	-	-	-	-	-
PBV_A Price To Book Value Adjusted	-10.9%	-18.8%	1.93	2.18	2.44	2.73	2.98	5.46	7.61	1.5	2.09	3.09	4.13
EVPerEBITDA_A EV Per EBITDA Ann.	-29.2%	-25.7%	9.2	17.5	22.4	25.9	36.9	40.5	-	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-29.3%	-31.2%	1.2	2.3	3.1	3.4	4.7	7.8	-	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	0.7%	0.3%	98.06%	97.59%	97.23%	96.14%	96.53%	96.79%	95.95%	80.64%			93.56%
EYield_A Earnings Yield Ann.	-	-	0.1	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.			0.1	0	0.1	0.1			0.2	0.1	0.2	0.4	0.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

10%

2Y CAGR

6.3%

3Y CAGR

12.1%

5Y CAGR

-9.7%

7Y CAGR

-15%

10Y CAGR

4.5%

ROE Annual % is stable compared to historical averages.

RoA Ann. %

1Y CHG

2.4%

2Y CAGR

3Y CAGR

8.5%

5Y CAGR

-11.1%

7Y CAGR

-10.9%

10Y CAGR

9.4%

RoA Annual % is stable compared to historical averages.

Current Ratio Ann.

1Y CHG

-15%

2Y CAGR

-7.8%

3Y CAGR

-6.8%

5Y CAGR

-6.7%

7Y CAGR

3.9%

10Y CAGR

4.4%

Current Ratio Annual is falling faster than historical averages.

Rossari Biotech cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Rossari Biotech Mar-2026 Cash From Operating Activity is Rs 59 Cr which is growth of -36.3% YoY.
POSITIVE
Net Cash Flow Rossari Biotech Mar-2026 Net Cash Flow is Rs 36 Cr which is growth of 464.8% YoY.

Rossari Biotech Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	-19.8%	2.4%	58.7	92.2	73.9	113.7	33.1	52.1	55.8	72.9	19.6	7.7	23.2
PBT_A PBT Ann.	26%	12.5%	191.1	154.7	134.1	95.6	106.7	106	88.1	64.5	39.4	18.9	4.8
INT_A Interest Ann.	42.8%	34.9%	13.4	9.6	9.7	4.6	2.5	3	3.7	3.3	1.4	2.1	3.4
TAX_A Tax Ann.	25.6%	12.4%	48.2	40	34.5	24.3	27.2	26.9	22.6	16.7	10.5	3.1	1.4
CFI_A Cash from Investing Act. Ann.	-	-	-101.4	-69.9	-69.6	-160.6	-318.1	-37	-187.3	-41.5	-17	-5.6	-4.7
CFA_A Cash from Financing Act. Ann.	8.9%	-	79.1	-32.3	-22.1	61.2	296.9	-29.5	155	-27.8	-3.7	-2.1	-17.5
NCF_A Net Cash Flow Ann. ⌄	36.7%	-	36.5	-10	-17.7	14.3	11.9	-14.4	23.5	3.6	-1.1	0.1	1.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-21.5%	-15.1%	12.9	22.6	40.5	26.7	14.8	29.2	5.7	1	2.1	2	1
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	5.9%	26.9%	48.7	12.9	22.6	41	26.7	14.8	29.2	4.6	1	2.1	2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-36.3%

2Y CAGR

-10.9%

3Y CAGR

-19.8%

5Y CAGR

2.4%

7Y CAGR

-3%

10Y CAGR

9.7%

Cash from Operating Activity Annual is falling faster than historical averages.

Cash from Financing Act. Ann.

3Y CAGR

8.9%

Cash from Financing Annual Activity growth is higher than historical averages.

Rossari Biotech investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

34.85% Fall from 52W High

Rossari Biotech quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Rossari Biotech - Forecaster

Forecaster Analyst Estimates for Rossari Biotech share price target, revenues, EPS, net income and more